antimycin a has been researched along with 3-bromo-2-oxopropionate-1-propyl ester in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akers, LJ; Fang, W; Franklin, AR; Huang, P; Levy, AG; Zweidler-McKay, PA | 1 |
1 other study(ies) available for antimycin a and 3-bromo-2-oxopropionate-1-propyl ester
Article | Year |
---|---|
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin.
Topics: Acute Disease; Adenosine Triphosphate; Antimycin A; Apoptosis; Caspase 3; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Glycolysis; HL-60 Cells; Humans; Hydrocarbons, Brominated; Immunoblotting; Jurkat Cells; Leukemia; Propionates; Sirolimus; Time Factors; U937 Cells | 2011 |